Literature DB >> 20510161

miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer.

Xiaobo Guo1, Lei Guo, Jun Ji, Jianian Zhang, Jun Zhang, Xuehua Chen, Qu Cai, Jianfang Li, Qinlong Gu, Bingya Liu, Zhenggang Zhu, Yingyan Yu.   

Abstract

Deregulation of E2F1 activity is characteristic of gastric tumorigenesis, which involves in complex molecular mechanisms. microRNA is one of the post-transcriptional regulators for gene expression. Here, we report a member of miR-331 family, miR-331-3p, which was decreased in some kinds of malignancies. However, the biological function of miR-331-3p on gastric cancer is largely unknown. In this study, we screened the expressing levels of miR-331-3p and E2F1 in gastric cancer cell lines. We transfected precursor or inhibitor of miR-331-3p into gastric cancer cells. As results, miR-331-3p is down-regulated in all gastric cancer cell lines by real-time PCR. Over-expression of miR-331-3p blocked G1/S transition on SGC-7901 and AGS cell lines. Introduction of miR-331-3p dramatically suppressed the ability of colony formation and cell growth in vitro by interfering E2F1 activity. Our data highlight an important role of miR-331-3p in cell cycle control by targeting 3'-UTR of cell cycle-related molecule E2F1. We concluded that miR-331-3p is a potential tumor suppressor in gastric cancer. Restoring miR-331-3p in gastric cancer cells revealed potential application in gastric cancer therapy. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20510161     DOI: 10.1016/j.bbrc.2010.05.082

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  55 in total

1.  Identification of microRNAs associated with lymphangiogenesis in human gastric cancer.

Authors:  B Yang; C Jing; J Wang; X Guo; Y Chen; R Xu; L Peng; J Liu; L Li
Journal:  Clin Transl Oncol       Date:  2013-07-24       Impact factor: 3.405

2.  Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.

Authors:  Lin Chen; Feihu Chu; Yali Cao; Jianguo Shao; Feng Wang
Journal:  Tumour Biol       Date:  2015-04-24

3.  Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma.

Authors:  Jing-jing Huang; Juan Yu; Jiang-yan Li; Yao-ting Liu; Ren-qian Zhong
Journal:  Med Oncol       Date:  2012-03-24       Impact factor: 3.064

Review 4.  MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.

Authors:  C Jiang; X Chen; M Alattar; J Wei; H Liu
Journal:  Cancer Gene Ther       Date:  2015-05-22       Impact factor: 5.987

Review 5.  MicroRNA and signaling pathways in gastric cancer.

Authors:  Z Zhang; Z Li; Y Li; A Zang
Journal:  Cancer Gene Ther       Date:  2014-07-25       Impact factor: 5.987

6.  Fluorescence activated cell sorting followed by small RNA sequencing reveals stable microRNA expression during cell cycle progression.

Authors:  Vince Kornél Grolmusz; Eszter Angéla Tóth; Kornélia Baghy; István Likó; Ottó Darvasi; Ilona Kovalszky; János Matkó; Károly Rácz; Attila Patócs
Journal:  BMC Genomics       Date:  2016-05-27       Impact factor: 3.969

Review 7.  Macro-management of microRNAs in cell cycle progression of tumor cells and its implications in anti-cancer therapy.

Authors:  Lin-hui Liang; Xiang-huo He
Journal:  Acta Pharmacol Sin       Date:  2011-09-12       Impact factor: 6.150

8.  Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells.

Authors:  Michael R Epis; Keith M Giles; Felicity C Kalinowski; Andrew Barker; Ronald J Cohen; Peter J Leedman
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

9.  Trichostatin A induces a unique set of microRNAs including miR-129-5p that blocks cyclin-dependent kinase 6 expression and proliferation in H9c2 cardiac myocytes.

Authors:  Gipsy Majumdar; Rajendra Raghow
Journal:  Mol Cell Biochem       Date:  2016-03-05       Impact factor: 3.396

Review 10.  Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma.

Authors:  Mitsuro Kanda; Hiroyuki Sugimoto; Yasuhiro Kodera
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.